OVINE CROTALIDAE VENOMS IMMUNE FAB

OVINE CROTALIDAE VENOMS IMMUNE FAB was reported 776 times

OVINE CROTALIDAE VENOMS IMMUNE FAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAEMOGLOBIN A2 1 0.5000
1 MANUAL LYMPHATIC DRAINAGE 1 0.0769
2 ADMINISTRATION SITE MOVEMENT IMPAIRMENT 1 0.0667
3 CHOROIDAL RUPTURE 1 0.0526
4 VENOM POISONING 1 0.0476
5 BLOOD FIBRINOGEN DECREASED 32 0.0280
6 FASCIOTOMY 3 0.0268
7 SNAKE BITE 2 0.0200
8 BLOOD PRESSURE DIFFERENCE OF EXTREMITIES 1 0.0172
9 PUNCTURE SITE PAIN 4 0.0172
10 TONGUE NECROSIS 1 0.0137
11 ELECTROCARDIOGRAM POOR R-WAVE PROGRESSION 2 0.0136
12 PERIPHERAL PULSE DECREASED 1 0.0103
13 PRODUCT RECONSTITUTION ISSUE 3 0.0095
14 FINGER AMPUTATION 7 0.0095
15 SKIN GRAFT FAILURE 1 0.0094
16 PROTHROMBIN TIME RATIO INCREASED 2 0.0092
17 ADMINISTRATION SITE EXTRAVASATION 9 0.0090
18 HOUSE DUST ALLERGY 1 0.0090
19 LABOUR INDUCTION 1 0.0074
20 TISSUE INJURY 3 0.0069
21 HAIR GROWTH RATE ABNORMAL 1 0.0068
22 TRACHEAL OEDEMA 1 0.0068
23 ADMINISTRATION SITE SWELLING 2 0.0062
24 BLOOD LACTIC ACID DECREASED 1 0.0058
25 COMPARTMENT SYNDROME 15 0.0057
26 DEBRIDEMENT 4 0.0052
27 EXSANGUINATION 1 0.0050
28 PROTHROMBIN TIME PROLONGED 30 0.0050
29 PULSE PRESSURE INCREASED 1 0.0048
30 PHARYNGEAL INJURY 1 0.0048
31 NEUROPSYCHIATRIC SYNDROME 1 0.0045
32 NEUROMUSCULAR BLOCKADE 1 0.0045
33 ACID BASE BALANCE ABNORMAL 1 0.0045
34 SKIN GRAFT 4 0.0043
35 PATIENT UNCOOPERATIVE 2 0.0042
36 CALCIUM IONISED DECREASED 1 0.0041
37 MYOGLOBIN URINE PRESENT 1 0.0041
38 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 1 0.0040
39 BLOOD FIBRINOGEN INCREASED 3 0.0038
40 METAL POISONING 2 0.0034
41 ENDOTRACHEAL INTUBATION COMPLICATION 2 0.0034
42 TISSUE INFILTRATION 1 0.0034
43 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
44 FIBRIN D DIMER INCREASED 12 0.0034
45 PRODUCT RECONSTITUTION QUALITY ISSUE 3 0.0034
46 MUSCLE NECROSIS 3 0.0033
47 FASCIITIS 2 0.0030
48 HYPOFIBRINOGENAEMIA 3 0.0030
49 NEONATAL RESPIRATORY DEPRESSION 1 0.0030
50 INFLAMMATION OF WOUND 1 0.0030
51 COAGULOPATHY 49 0.0029
52 PRODUCT COMPOUNDING QUALITY ISSUE 1 0.0027
53 ECCHYMOSIS 18 0.0026
54 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 1 0.0026
55 COAGULATION TEST ABNORMAL 2 0.0026
56 SERUM SICKNESS 7 0.0025
57 NECROSIS 13 0.0023
58 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1 0.0022
59 ANAPHYLACTOID REACTION 9 0.0022
60 EPIDERMOLYSIS 1 0.0022
61 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 11 0.0022
62 VEIN DISCOLOURATION 1 0.0021
63 WOUND NECROSIS 1 0.0021
64 VITREOUS DISORDER 1 0.0021
65 HYPOCOAGULABLE STATE 2 0.0021
66 THERAPY CHANGE 17 0.0017
67 MUCOSAL HAEMORRHAGE 2 0.0017
68 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
69 PUPILLARY DISORDER 1 0.0016
70 EXTREMITY CONTRACTURE 1 0.0016
71 DELIVERY 1 0.0015
72 EXTRAVASATION 6 0.0015
73 PCO2 INCREASED 1 0.0014
74 PRODUCT SOLUBILITY ABNORMAL 7 0.0014
75 RESPIRATORY TRACT OEDEMA 1 0.0013
76 LOCAL REACTION 1 0.0013
77 SKIN NECROSIS 7 0.0013
78 SOFT TISSUE INJURY 1 0.0013
79 TRACHEITIS 1 0.0013
80 BLOOD BLISTER 4 0.0013
81 LABORATORY TEST INTERFERENCE 1 0.0013
82 TENDERNESS 13 0.0012
83 INTERNATIONAL NORMALISED RATIO DECREASED 5 0.0012
84 INCISION SITE HAEMORRHAGE 1 0.0012
85 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
86 OCULAR VASCULAR DISORDER 1 0.0012
87 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
88 LUNG HYPERINFLATION 1 0.0012
89 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
90 EXTREMITY NECROSIS 2 0.0011
91 UPPER AIRWAY OBSTRUCTION 1 0.0011
92 PNEUMOMEDIASTINUM 2 0.0011
93 PRODUCT PREPARATION ISSUE 7 0.0011
94 WOUND SECRETION 4 0.0010
95 DIPLEGIA 2 0.0010
96 SKIN OEDEMA 1 0.0010
97 ANAPHYLACTIC REACTION 53 0.0010
98 WALKING DISABILITY 2 0.0010
99 SOFT TISSUE DISORDER 1 0.0009
100 KOUNIS SYNDROME 2 0.0009
101 HAEMATOCRIT INCREASED 2 0.0009
102 ADMINISTRATION SITE PAIN 1 0.0009
103 INTERCEPTED MEDICATION ERROR 4 0.0009
104 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
105 UNDERDOSE 62 0.0008
106 STREPTOCOCCAL SEPSIS 1 0.0008
107 PHARYNGEAL HAEMORRHAGE 1 0.0008
108 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
109 AMPUTATION 1 0.0008
110 SWELLING 75 0.0008
111 PRODUCT PREPARATION ERROR 16 0.0008
112 IATROGENIC INJURY 1 0.0008
113 DRUG EFFECT INCOMPLETE 28 0.0008
114 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
115 IMMUNOGLOBULINS DECREASED 1 0.0007
116 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
117 HAEMATOCRIT DECREASED 14 0.0007
118 INTENSIVE CARE 1 0.0007
119 INVESTIGATION ABNORMAL 1 0.0007
120 GASTROINTESTINAL NECROSIS 2 0.0007
121 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
122 STRIDOR 2 0.0007
123 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
124 COAGULATION TIME PROLONGED 1 0.0006
125 OPHTHALMOPLEGIA 1 0.0006
126 INTERNATIONAL NORMALISED RATIO INCREASED 18 0.0006
127 LOCAL SWELLING 11 0.0006
128 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
129 GAZE PALSY 1 0.0006
130 BLOOD PH DECREASED 1 0.0006
131 BLOOD CHLORIDE INCREASED 1 0.0006
132 TREATMENT DELAYED 1 0.0006
133 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
134 INDURATION 1 0.0006
135 THROMBOCYTOPENIA 62 0.0006
136 WOUND HAEMORRHAGE 2 0.0005
137 INJECTION SITE CELLULITIS 1 0.0005
138 MECHANICAL VENTILATION 1 0.0005
139 MENOMETRORRHAGIA 1 0.0005
140 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
141 TRAUMATIC LUNG INJURY 1 0.0005
142 PLATELET COUNT DECREASED 54 0.0005
143 BRAIN INJURY 5 0.0005
144 MUSCLE HAEMORRHAGE 2 0.0005
145 PETECHIAE 5 0.0005
146 LIVEDO RETICULARIS 1 0.0005
147 TORTICOLLIS 1 0.0005
148 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
149 EXOPHTHALMOS 1 0.0005
150 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
151 PRODUCT LOT NUMBER ISSUE 1 0.0005
152 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
153 HAEMANGIOMA 1 0.0004
154 NEUROLOGICAL DECOMPENSATION 1 0.0004
155 SKIN ABRASION 2 0.0004
156 MOBILITY DECREASED 30 0.0004
157 PERIPHERAL SWELLING 64 0.0004
158 PULSE ABNORMAL 1 0.0004
159 CATHETER SITE HAEMORRHAGE 1 0.0004
160 PLATELET DISORDER 1 0.0004
161 TOE AMPUTATION 2 0.0004
162 SEDATION COMPLICATION 1 0.0004
163 FOOD ALLERGY 3 0.0004
164 ANAPHYLACTIC SHOCK 10 0.0004
165 ANGIOEDEMA 17 0.0004
166 AREFLEXIA 1 0.0004
167 JOINT RANGE OF MOTION DECREASED 5 0.0004
168 BLOOD SODIUM INCREASED 1 0.0004
169 OEDEMA 20 0.0004
170 SUBDURAL HAEMORRHAGE 1 0.0004
171 TENOSYNOVITIS 1 0.0004
172 VITREOUS HAEMORRHAGE 1 0.0004
173 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
174 MACULE 1 0.0004
175 BLOOD UREA INCREASED 6 0.0004
176 ENDOTRACHEAL INTUBATION 1 0.0004
177 OXYGEN SATURATION ABNORMAL 1 0.0004
178 PERONEAL NERVE PALSY 2 0.0004
179 SKIN WARM 2 0.0003
180 URINE OUTPUT DECREASED 3 0.0003
181 BRADYCARDIA 18 0.0003
182 RESPIRATORY RATE INCREASED 3 0.0003
183 BRAIN HERNIATION 1 0.0003
184 HYPOAESTHESIA ORAL 5 0.0003
185 PLATELET COUNT ABNORMAL 2 0.0003
186 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
187 LARYNGEAL OEDEMA 2 0.0003
188 BRAIN DEATH 1 0.0003
189 BRAIN OEDEMA 4 0.0003
190 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
191 PHARYNGEAL SWELLING 3 0.0003
192 LYMPHOCYTE COUNT INCREASED 1 0.0003
193 OEDEMA MOUTH 1 0.0003
194 INFUSION SITE HAEMORRHAGE 1 0.0003
195 EXPOSURE DURING BREAST FEEDING 1 0.0003
196 GINGIVAL BLEEDING 4 0.0003
197 BLOOD CREATININE ABNORMAL 1 0.0003
198 HYPOPNOEA 1 0.0003
199 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
200 TYPE I HYPERSENSITIVITY 1 0.0003
201 BONE EROSION 1 0.0003
202 SINUS TACHYCARDIA 4 0.0003
203 CONTUSION 27 0.0003
204 BRONCHOSPASM 4 0.0003
205 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 50 0.0003
206 PARAESTHESIA ORAL 4 0.0003
207 VENTRICULAR ARRHYTHMIA 1 0.0003
208 MOUTH HAEMORRHAGE 2 0.0003
209 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
210 PROTEIN TOTAL DECREASED 1 0.0003
211 LOSS OF CONTROL OF LEGS 1 0.0003
212 PRODUCT AVAILABILITY ISSUE 6 0.0003
213 HAEMODYNAMIC INSTABILITY 2 0.0003
214 TONGUE OEDEMA 1 0.0003
215 ACIDOSIS 2 0.0003
216 SKIN DISCOLOURATION 12 0.0003
217 SHOCK 6 0.0003
218 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
219 BLOOD DISORDER 2 0.0002
220 ARTERIOSPASM CORONARY 1 0.0002
221 SENSORY LOSS 2 0.0002
222 MUSCLE TIGHTNESS 4 0.0002
223 BODY TEMPERATURE INCREASED 5 0.0002
224 URTICARIA 41 0.0002
225 HYPERAESTHESIA 2 0.0002
226 INJECTION SITE EXTRAVASATION 3 0.0002
227 LEG AMPUTATION 1 0.0002
228 ACCIDENTAL EXPOSURE 1 0.0002
229 LABORATORY TEST ABNORMAL 7 0.0002
230 LIP OEDEMA 1 0.0002
231 ABSCESS LIMB 1 0.0002
232 TENSION HEADACHE 1 0.0002
233 ANURIA 2 0.0002
234 HYPERSENSITIVITY 43 0.0002
235 BLISTER 13 0.0002
236 IMMOBILE 1 0.0002
237 GROIN PAIN 2 0.0002
238 ABDOMINAL ABSCESS 1 0.0002
239 PHYSICAL DISABILITY 1 0.0002
240 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
241 HYPOTENSION 44 0.0002
242 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
243 EAR DISORDER 1 0.0002
244 CELLULITIS 11 0.0002
245 LOCALISED OEDEMA 1 0.0002
246 DIARRHOEA HAEMORRHAGIC 2 0.0002
247 SKIN TIGHTNESS 1 0.0002
248 DIALYSIS 3 0.0002
249 PULSE ABSENT 1 0.0002
250 ACUTE RESPIRATORY FAILURE 4 0.0002
251 GUILLAIN-BARRE SYNDROME 1 0.0002
252 HYPERVOLAEMIA 1 0.0002
253 HYPERAMMONAEMIA 1 0.0002
254 SUBARACHNOID HAEMORRHAGE 2 0.0002
255 PHLEBITIS 1 0.0002
256 PERIPHERAL VASCULAR DISORDER 1 0.0002
257 MUSCULOSKELETAL STIFFNESS 17 0.0002
258 HAEMOGLOBIN DECREASED 19 0.0002
259 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
260 NONSPECIFIC REACTION 1 0.0002
261 INTESTINAL ISCHAEMIA 1 0.0002
262 CHOKING SENSATION 1 0.0002
263 BLOOD PRESSURE DECREASED 12 0.0002
264 ERYTHEMA 37 0.0002
265 NERVE INJURY 2 0.0002
266 MULTI-ORGAN FAILURE 3 0.0002
267 HEART RATE DECREASED 6 0.0002
268 WHEEZING 10 0.0002
269 CHOLECYSTITIS 2 0.0002
270 GANGRENE 1 0.0002
271 CYTOPENIA 2 0.0002
272 INTERCEPTED PRODUCT PREPARATION ERROR 2 0.0002
273 INFUSION SITE EXTRAVASATION 1 0.0002
274 PRE-EXISTING CONDITION IMPROVED 1 0.0002
275 DERMATITIS ALLERGIC 2 0.0002
276 SCREAMING 1 0.0002
277 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
278 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
279 HAEMOGLOBIN ABNORMAL 1 0.0002
280 PLATELET COUNT INCREASED 2 0.0002
281 IMMUNE SYSTEM DISORDER 2 0.0002
282 ADVERSE REACTION 2 0.0002
283 LIP SWELLING 5 0.0001
284 SKIN MASS 1 0.0001
285 PRODUCT ADMINISTRATION ERROR 3 0.0001
286 POSTOPERATIVE WOUND INFECTION 1 0.0001
287 LIMB INJURY 4 0.0001
288 INFARCTION 1 0.0001
289 RESPIRATION ABNORMAL 1 0.0001
290 JOINT EFFUSION 1 0.0001
291 RESPIRATORY DISTRESS 4 0.0001
292 LYMPHOEDEMA 1 0.0001
293 DEFAECATION URGENCY 1 0.0001
294 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
295 THERMAL BURN 1 0.0001
296 IMPAIRED WORK ABILITY 3 0.0001
297 PARALYSIS 2 0.0001
298 HYPOKINESIA 2 0.0001
299 INFUSION RELATED REACTION 9 0.0001
300 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
301 TACHYCARDIA 12 0.0001
302 EYE SWELLING 5 0.0001
303 BLOOD COUNT ABNORMAL 2 0.0001
304 PROCEDURAL COMPLICATION 1 0.0001
305 PHARYNGEAL OEDEMA 2 0.0001
306 PAIN 79 0.0001
307 RASH 56 0.0001
308 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
309 CYANOSIS 2 0.0001
310 FURUNCLE 1 0.0001
311 BLOOD ALBUMIN DECREASED 1 0.0001
312 GINGIVAL PAIN 1 0.0001
313 LOCALISED INFECTION 3 0.0001
314 MUSCLE DISORDER 1 0.0001
315 SHOCK HAEMORRHAGIC 1 0.0001
316 ASPHYXIA 1 0.0001
317 HEMIPLEGIA 1 0.0001
318 PNEUMONIA ASPIRATION 3 0.0001
319 RHABDOMYOLYSIS 5 0.0001
320 INFUSION SITE ERYTHEMA 1 0.0001
321 FACE OEDEMA 2 0.0001
322 HEMIPARESIS 2 0.0001
323 HAEMATURIA 4 0.0001
324 UNRESPONSIVE TO STIMULI 3 0.0001
325 BLOOD MAGNESIUM DECREASED 1 0.0001
326 OEDEMA PERIPHERAL 14 0.0001
327 NEUROTOXICITY 2 0.0001
328 GRIP STRENGTH DECREASED 1 0.0001
329 HYPOXIA 4 0.0001
330 COLD SWEAT 2 0.0001
331 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
332 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
333 MYOSITIS 1 0.0001
334 HYPERHIDROSIS 14 0.0001
335 FLANK PAIN 1 0.0001
336 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
337 POST PROCEDURAL COMPLICATION 2 0.0001
338 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
339 MENORRHAGIA 2 0.0001
340 PRESCRIBED UNDERDOSE 2 0.0001
341 DISCOMFORT 6 0.0001
342 MOTOR DYSFUNCTION 1 0.0001
343 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
344 EXPOSURE DURING PREGNANCY 6 0.0001
345 NERVOUS SYSTEM DISORDER 3 0.0001
346 PRODUCT QUALITY ISSUE 13 0.0001
347 HAEMORRHAGE 10 0.0001
348 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
349 EPISTAXIS 7 0.0001
350 MOVEMENT DISORDER 3 0.0001
351 LIVER FUNCTION TEST INCREASED 2 0.0001
352 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
353 BLOOD CREATININE INCREASED 6 0.0001
354 WOUND INFECTION 1 0.0001
355 ASPIRATION 1 0.0001
356 RENAL FAILURE 12 0.0001
357 FOOT DEFORMITY 1 0.0001
358 RASH MACULO-PAPULAR 2 0.0001
359 GAIT INABILITY 3 0.0001
360 INTESTINAL PERFORATION 1 0.0001
361 OCULAR DISCOMFORT 1 0.0001
362 BLOOD CALCIUM DECREASED 1 0.0001
363 CHROMATURIA 2 0.0001
364 EYELID OEDEMA 1 0.0001
365 CEREBRAL HAEMORRHAGE 3 0.0001
366 PRURITUS 32 0.0001
367 NEURALGIA 2 0.0001
368 NO THERAPEUTIC RESPONSE 1 0.0001
369 CEREBRAL INFARCTION 2 0.0001
370 RESPIRATORY DEPRESSION 1 0.0001
371 LIVER INJURY 2 0.0001
372 ABASIA 2 0.0001
373 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
374 HYPOAESTHESIA 12 0.0001
375 OFF LABEL USE 70 0.0001
376 MUSCLE ATROPHY 1 0.0001
377 HAEMATEMESIS 2 0.0001
378 PAIN IN EXTREMITY 23 0.0001
379 MYDRIASIS 1 0.0001
380 INFLAMMATION 4 0.0001
381 HAEMATOMA 2 0.0001
382 SWELLING FACE 5 0.0001
383 JOINT STIFFNESS 2 0.0001
384 PULMONARY CONGESTION 1 0.0001
385 ABORTION SPONTANEOUS 3 0.0001
386 HAEMATOCHEZIA 4 0.0001
387 ORAL DISCOMFORT 1 0.0001
388 NO ADVERSE EVENT 13 0.0001
389 SKIN REACTION 1 0.0001
390 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
391 PARAESTHESIA 11 0.0001
392 CARDIOGENIC SHOCK 1 0.0001
393 RESPIRATORY FAILURE 5 0.0001
394 AGITATION 5 0.0001
395 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
396 SKIN HAEMORRHAGE 1 0.0001
397 HAEMORRHAGE INTRACRANIAL 1 0.0001
398 RESPIRATORY DISORDER 2 0.0001
399 BLOOD POTASSIUM DECREASED 2 0.0001
400 LACRIMATION INCREASED 2 0.0001
401 CONDITION AGGRAVATED 20 0.0001
402 DRUG ADMINISTRATION ERROR 2 0.0001
403 SWOLLEN TONGUE 2 0.0001
404 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
405 PNEUMOTHORAX 1 0.0001
406 METABOLIC ACIDOSIS 2 0.0001
407 CHOLELITHIASIS 2 0.0001
408 ACUTE KIDNEY INJURY 9 0.0001
409 CIRCULATORY COLLAPSE 1 0.0001
410 SCAR 1 0.0001
411 AMENORRHOEA 1 0.0001
412 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
413 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
414 LEUKOCYTOSIS 1 0.0001
415 PELVIC PAIN 1 0.0001
416 BLOOD SODIUM DECREASED 1 0.0001
417 PULMONARY EMBOLISM 5 0.0001
418 MUSCULOSKELETAL DISORDER 1 0.0001
419 DRUG PRESCRIBING ERROR 1 0.0001
420 SKIN FISSURES 1 0.0001
421 HEART RATE INCREASED 5 0.0001
422 FLUSHING 5 0.0000
423 CARDIAC ARREST 4 0.0000
424 CARDIO-RESPIRATORY ARREST 2 0.0000
425 DERMATITIS 1 0.0000
426 GAIT DISTURBANCE 9 0.0000
427 PRURITUS GENERALISED 1 0.0000
428 DEEP VEIN THROMBOSIS 3 0.0000
429 VAGINAL HAEMORRHAGE 2 0.0000
430 PRODUCT DISPENSING ERROR 1 0.0000
431 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
432 TRANSAMINASES INCREASED 1 0.0000
433 VOMITING 21 0.0000
434 RASH PAPULAR 1 0.0000
435 SNEEZING 1 0.0000
436 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
437 THROAT IRRITATION 2 0.0000
438 HEART RATE IRREGULAR 1 0.0000
439 SKIN IRRITATION 2 0.0000
440 MUSCLE TWITCHING 1 0.0000
441 CHEST PAIN 8 0.0000
442 HYPERTENSION 9 0.0000
443 OCULAR HYPERAEMIA 2 0.0000
444 RASH ERYTHEMATOUS 2 0.0000
445 MENTAL IMPAIRMENT 1 0.0000
446 PRESYNCOPE 1 0.0000
447 DYSPNOEA 23 0.0000
448 CHEST DISCOMFORT 4 0.0000
449 LOSS OF CONSCIOUSNESS 5 0.0000
450 THERAPY CESSATION 2 0.0000
451 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
452 NERVOUSNESS 2 0.0000
453 APPLICATION SITE ERYTHEMA 1 0.0000
454 JAUNDICE 1 0.0000
455 PALLOR 1 0.0000
456 RESPIRATORY ARREST 1 0.0000
457 MENTAL STATUS CHANGES 1 0.0000
458 FEELING COLD 1 0.0000
459 OXYGEN SATURATION DECREASED 2 0.0000
460 EYE PAIN 2 0.0000
461 NAUSEA 28 0.0000
462 RED BLOOD CELL COUNT DECREASED 1 0.0000
463 DYSPHONIA 2 0.0000
464 NASAL CONGESTION 2 0.0000
465 URINARY INCONTINENCE 1 0.0000
466 HEPATIC FAILURE 1 0.0000
467 ADVERSE EVENT 3 0.0000
468 DEATH 27 0.0000
469 OSTEONECROSIS 1 0.0000
470 ABDOMINAL PAIN 7 0.0000
471 EXPIRED PRODUCT ADMINISTERED 1 0.0000
472 SYNCOPE 3 0.0000
473 SKIN DISORDER 1 0.0000
474 URINARY RETENTION 1 0.0000
475 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
476 FEELING ABNORMAL 7 0.0000
477 MYOCARDIAL INFARCTION 5 0.0000
478 C-REACTIVE PROTEIN INCREASED 1 0.0000
479 PANIC ATTACK 1 0.0000
480 DRUG INEFFECTIVE 35 0.0000
481 BLOOD GLUCOSE INCREASED 5 0.0000
482 UNEVALUABLE EVENT 2 0.0000
483 INCORRECT DOSE ADMINISTERED 6 0.0000
484 ANAEMIA 5 0.0000
485 SEIZURE 3 0.0000
486 PALPITATIONS 3 0.0000
487 THROMBOSIS 2 0.0000
488 SOMNOLENCE 5 0.0000
489 EXTRA DOSE ADMINISTERED 1 0.0000
490 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
491 ANXIETY 7 0.0000
492 BLINDNESS 1 0.0000
493 NEUTROPHIL COUNT DECREASED 1 0.0000
494 VISUAL IMPAIRMENT 3 0.0000
495 TREATMENT FAILURE 2 0.0000
496 ROAD TRAFFIC ACCIDENT 1 0.0000
497 SKIN EXFOLIATION 2 0.0000
498 OSTEOARTHRITIS 1 0.0000
499 RENAL FAILURE ACUTE 1 0.0000
500 RECTAL HAEMORRHAGE 1 0.0000
501 HYPOACUSIS 1 0.0000
502 OVERDOSE 5 0.0000
503 BALANCE DISORDER 2 0.0000
504 SEPTIC SHOCK 1 0.0000
505 PULMONARY OEDEMA 1 0.0000
506 ADVERSE DRUG REACTION 2 0.0000
507 NEPHROLITHIASIS 1 0.0000
508 OROPHARYNGEAL PAIN 2 0.0000
509 RENAL DISORDER 1 0.0000
510 COGNITIVE DISORDER 1 0.0000
511 ARRHYTHMIA 1 0.0000
512 DISEASE RECURRENCE 1 0.0000
513 BLOOD GLUCOSE DECREASED 1 0.0000
514 LUNG DISORDER 1 0.0000
515 PYREXIA 7 0.0000
516 DRY EYE 1 0.0000
517 AGGRESSION 1 0.0000
518 BLOOD PRESSURE INCREASED 3 0.0000
519 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
520 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
521 DEPRESSED MOOD 1 0.0000
522 RASH PRURITIC 1 0.0000
523 TREATMENT NONCOMPLIANCE 1 0.0000
524 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
525 MEDICATION ERROR 1 0.0000
526 MUSCULAR WEAKNESS 2 0.0000
527 CHILLS 2 0.0000
528 SURGERY 1 0.0000
529 ARTHRALGIA 7 0.0000
530 ILL-DEFINED DISORDER 1 0.0000
531 PLEURAL EFFUSION 1 0.0000
532 FEELING HOT 1 0.0000
533 RHINORRHOEA 1 0.0000
534 INJECTION SITE PRURITUS 1 0.0000
535 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
536 HEPATIC ENZYME INCREASED 1 0.0000
537 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
538 VISION BLURRED 2 0.0000
539 BURNING SENSATION 1 0.0000
540 INJURY 1 0.0000
541 SKIN BURNING SENSATION 1 0.0000
542 INFECTION 2 0.0000
543 DYSGEUSIA 1 0.0000
544 HEADACHE 8 0.0000
545 CARDIAC FAILURE 1 0.0000
546 DRUG DOSE OMISSION 2 0.0000
547 COMPLETED SUICIDE 1 0.0000
548 RENAL IMPAIRMENT 1 0.0000
549 CEREBROVASCULAR ACCIDENT 2 0.0000
550 MYALGIA 2 0.0000
551 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
552 WEIGHT DECREASED 3 0.0000
553 NEUROPATHY PERIPHERAL 1 0.0000
554 ATRIAL FIBRILLATION 1 0.0000
555 DIARRHOEA 6 0.0000
556 PNEUMONIA 3 0.0000
557 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
558 CONSTIPATION 2 0.0000
559 SEPSIS 1 0.0000
560 WEIGHT INCREASED 2 0.0000
561 ASTHMA 1 0.0000
562 DEPRESSION 2 0.0000
563 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
564 BACK PAIN 2 0.0000
565 DISEASE PROGRESSION 1 0.0000
566 JOINT SWELLING 1 0.0000
567 INJECTION SITE ERYTHEMA 1 0.0000
568 FATIGUE 6 0.0000
569 INSOMNIA 2 0.0000
570 MEMORY IMPAIRMENT 1 0.0000
571 COUGH 2 0.0000
572 HOSPITALISATION 1 0.0000
573 CONFUSIONAL STATE 1 0.0000
574 TREMOR 1 0.0000
575 ABDOMINAL DISCOMFORT 1 0.0000
576 MUSCLE SPASMS 1 0.0000
577 ABDOMINAL PAIN UPPER 1 0.0000
578 MALAISE 2 0.0000
579 DECREASED APPETITE 1 0.0000
580 DIZZINESS 2 0.0000
581 ASTHENIA 1 0.0000